Page last updated: 2024-08-17

medroxyprogesterone acetate and Apparent Mineralocorticoid Excess Syndrome

medroxyprogesterone acetate has been researched along with Apparent Mineralocorticoid Excess Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Irish, A; Kong, WY; Leedman, P1

Other Studies

1 other study(ies) available for medroxyprogesterone acetate and Apparent Mineralocorticoid Excess Syndrome

ArticleYear
A case of iatrogenic Cushing syndrome and apparent mineralocorticoid excess presenting with accelerated hypertension and proteinuria.
    Internal medicine journal, 2014, Volume: 44, Issue:9

    Topics: Antineoplastic Agents, Hormonal; Cushing Syndrome; Female; Humans; Hypertension; Iatrogenic Disease; Medroxyprogesterone Acetate; Middle Aged; Mineralocorticoid Excess Syndrome, Apparent; Proteinuria; Treatment Outcome

2014